Literature DB >> 35194155

Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.

Shukaib Arslan1, Haris Ali2, Mathew Mei2, Guido Marcucci2, Stephan Forman2, Ryotaro Nakamura2, Anthony Stein2, Monzr M Al Malki2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35194155     DOI: 10.1038/s41409-022-01590-0

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  1 in total

1.  Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.

Authors:  Grzegorz Helbig; Beata Stella-Holowiecka; Malgorzata Krawczyk-Kulis; Jerzy Wojnar; Miroslaw Markiewicz; Maria Wojciechowska-Sadus; Malgorzata Kopera; Tomasz Kruzel; Jacek Najda; Katarzyna Nowak; Jerzy Holowiecki
Journal:  Haematologica       Date:  2005-11       Impact factor: 9.941

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.